Discover

SRTS
Sensus Healthcare, Inc.
3.03
2 x 2.18
2 x 3.89
bid
ask
+
0.01
0.33%
2 @ 04:00 PM
3.04 +0.01 (0.33%)
Ytd-23.87%
1y-34.70%
3.02
day range
3.07
2.66
52 week range
5.92
Open3.04Prev Close3.02Low3.02High3.07Mkt Cap49.88M
Vol45.94KAvg Vol60.83KEPS-0.47P/EN/AForward P/E11.84
Beta1.04Short Ratio6.14Inst. Own24.27%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0650-d Avg3.27200-d Avg3.831yr Est11.50
Earning
DateForEstimateReportedSurprisesurprise %
2025-02-132024-120.1N/AN/AN/A
2024-11-142024-09-0.020.070.09450.00%
2024-08-082024-060.030.10.07233.33%
2024-05-092024-03-0.040.140.18450.00%
2024-02-082023-120.120.260.14116.67%
2023-11-092023-09-0.01-0.09-0.08-800.00%
Upgrade / Downgrade
DateFirmActionFromTo
2024-11-18HC Wainwright & Co.UpgradeBuyBuy
2024-11-15Maxim GroupUpgradeBuyBuy
2024-08-12HC Wainwright & Co.UpgradeBuyBuy
2024-05-13HC Wainwright & Co.UpgradeBuyBuy
2024-05-10Maxim GroupUpgradeBuyBuy
2023-11-13HC Wainwright & Co.UpgradeBuyBuy
Profile
Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.
Insider Holder
DateNameRelationQuantityDescription
2024-12-16CORNISH MEGANDirector32.00KStock Award(Grant)
2024-05-19HEINRICH JOHN P. PH.D.Director59.94KSale
2024-12-16MCCALL WILLIAM HDirector30.00KStock Award(Grant)
2023-05-08O'REAR SAMUELDirector143.57KPurchase
2024-12-16PETRELLI ANTHONY BENEDICTDirector66.47KStock Award(Grant)
2023-09-13SARDANO JOSEPH CChief Executive Officer1.18MPurchase
Institution Ownership
Report DateOrganizationPositionValuePercentage
2024-09-29Vanguard Group Inc779.05K5.35M4.75%
2024-09-29Renaissance Technologies, LLC409.33K2.81M2.50%
2024-09-29Acadian Asset Management. LLC303.92K2.09M1.85%
2024-09-29Dimensional Fund Advisors LP289.62K1.99M1.77%
2024-09-29Morgan Stanley185.27K1.27M1.13%
2024-09-29Two Sigma Investments, LP154.04K1.06M0.94%
Fund Ownership
Report DateOrganizationPositionValuePercentage
2024-09-29Vanguard Total Stock Market Index Fund555.56K3.82M3.39%
2024-09-29Vanguard Extended Market Index Fund207.42K1.42M1.27%
2024-09-29Perritt Microcap Opportunities Fund95.00K652.65K0.58%
2024-10-30Fidelity Extended Market Index Fund76.08K522.67K0.46%
2024-10-30Unified Series Trust-Auer Growth Fd50.00K343.50K0.31%
2024-10-30iShares Micro Cap ETF34.23K235.15K0.21%